The new epidemiology of heart failure

Current Cardiology Reports

Volumn 5, Issue 3, 2003, Pages 181-186

  Rodeheffer, Richard J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; GLYCERYL TRINITRATE; HYDRALAZINE; VASODILATOR AGENT;

AGE; CLINICAL FEATURE; CLINICAL TRIAL; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FUNCTION; HUMAN; MEDICAL ASSESSMENT; MEDICAL RESEARCH; PATIENT REFERRAL; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL; SYMPTOMATOLOGY; CONGESTIVE HEART FAILURE; DIASTOLE; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SYSTOLE;

DIASTOLE; HEART FAILURE, CONGESTIVE; HUMANS; PREVALENCE; RISK FACTORS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0038749486     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0046-8     Document Type: Review

References (31)

1. McKee PA, Castelli WP, McNamara PM, Kannel WB: The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971, 285:1441-1446.
2. Rodeheffer RJ, Jacobsen SL, Gersh BJ, et al.: The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993, 68:1143-1150.
3. Remes J, Reunanen A, Aromaa A, Pyorala K: Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J 1992, 13:588-593.
4. Schocken DD, Arrieta MI, Leaverton PE, Ross EA: Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992, 20:301-306.
5. Congestive heart failure in the United States: a new epidemic. National Heart Lung and Blood Institute fact sheet. Bethesda: National Heart Lung and Blood Institute; 1996.
6. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685-691.
7. Pfeffer MA, Braunwald E, Moye LA, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992, 327:669-677.
8. McDonagh TA, Morrison CE, Lawrence A, et al.: Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997, 350:829-833.
9. Redfield MM, Jacobsen SJ, Burnett JC, Jr, et al.: Burden of systolic and diastolic ventricular dysfunction in the community. JAMA 2003, 289:194-202.
10. Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565-1574.
11. Kitzman DW, Gardin JM, Gottdiener JS, et al.: Importance of heart failure with preserved systolic function in patients ≥ 65 years of age. Am J Cardiol 2001, 87:413-419.
12. Davies MK, Hobbs FDR, Davis RC, et al.: Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population-based study. Lancet 2001, 358:439-444.
13. Gottdiener JS, Arnold AM, Aurigemma GP, et al.: Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000, 35:1628-1637.
14. Levy D, Garrison RJ, Savage DD, et al.: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561-1566.
15. Gardin JM, McClelland R, Kitzman D, et al.: M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in elderly cohort (The Cardiovascular Health Study). Am J Cardiol 2001, 87:1051-1057.
16. Vasan RS, Larson MG, Benjamin EJ, et al.: Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997, 336:1350-1355.
17. Kenchaiah S, Evans JC, Levy D, et al.: Obesity and the risk of heart failure. N Engl J Med 2002, 347:305-313.
18. Ho KKL, Anderson KM, Kannel WB, et al.: Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 1993, 88:107-115.
19. Senni M, Redfield MM: Congestive heart failure in elderly patients. Mayo Clin Proc 1997, 72:453-460.
20. Senni M, Tribouilloy CM, Rodeheffer RJ, et al.: Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998, 98:2282-2289.
21. Senni M, Tribouilloy CM, Rodeheffer RJ, et al.: Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 1999, 159:29-34.
22. Levy D, Kenchaiah S, Larson MG, et al.: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397-1402.
23. Massie BM, Conway M: Survival of patients with congestive heart failure: Past, present, and future prospects. Circulation 1987, 75(Suppl IV):IV-11-IV-19.
24. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987, 316:1429-1435.
25. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991, 325:293-302.
26. McDonagh TA, Robb SD, Murdoch DR, et al.: Biochemical detection of left ventricular systolic dysfunction. Lancet 1998, 351:9-13.
27. Vasan RS, Benjamin EJ, Larson MG, et al.: Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. The Framingham Heart Study. JAMA 2002, 288:1252-1259.
28. Devereux RB, Roman MJ, Paranicas M, et al.: A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Am Heart J 2001, 141:439-446.
29. Gardin JM, Siscovick D, Anton-Culver H, et al.: Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. Circulation 1995, 91:1739-1748.
30. Bröckel U, Hense HW, Muscholl M, et al.: Prevalence of left ventricular dysfunction in the general population 901-66. J Am Coll Cardiol 1996, 27(Suppl 2):1.
31. Mosterd A, Hoes AW, de Bruyne MC, et al.: Prevalence of heart failure and left ventricular dysfunction in the general population: The Rotterdam study. Eur Heart J 1999, 20:447-455.